IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported financial results for the third quarter of 2023.
- Revenues came in at $3.74 billion in the September quarter, which is up 4.9% from the prior-year quarter
- Third-quarter net Income, on a reported basis, increased 7.1% annually to $303 million; EPS rose 9.4% to $1.63
- Adjusted earnings per share, excluding special items, edged up 0.4% year-over-year to $2.49 per share
- Adjusted EBITDA was $888 million during the three-month period, up 9.1% year-over-year
- R&D Solutions quarterly bookings were $2.6 billion in Q3, representing a book-to-bill ratio of 1.24x
- There was an R&D solution contracted backlog of $28.8 billion, which is up 12% year-over-year
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
